Jingkun Zeng - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Jingkun Zeng

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

The Biochemical Journal|July 1, 2021

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonucleaseBerta Canal, Allison W McClure, Joseph F Curran, et al.

The Biochemical Journal|July 1, 2021

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp3 papain-like proteaseChew Theng Lim, Kang Wei Tan, Mary Wu, et al.

Biorxiv : the Preprint Server for Biology|May 18, 2026

Selective Elimination of TP53 Mutant Cells by Transcript-Activated Chromatin ShreddingJingkun Zeng, Zhiyuan Cheng, Huadong Chen, et al.

Nature|June 8, 2026

Targeting Cancer-Specific Mutations with RNA-Triggered Chromatin ShreddingJingkun Zeng, Zhiyuan Cheng, Huadong Chen, et al.

Pageof 2

Search research articles

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

The Biochemical Journal|July 1, 2021

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonucleaseBerta Canal, Allison W McClure, Joseph F Curran, et al.

The Biochemical Journal|July 1, 2021

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp3 papain-like proteaseChew Theng Lim, Kang Wei Tan, Mary Wu, et al.

Biorxiv : the Preprint Server for Biology|May 18, 2026

Selective Elimination of TP53 Mutant Cells by Transcript-Activated Chromatin ShreddingJingkun Zeng, Zhiyuan Cheng, Huadong Chen, et al.

Nature|June 8, 2026

Targeting Cancer-Specific Mutations with RNA-Triggered Chromatin ShreddingJingkun Zeng, Zhiyuan Cheng, Huadong Chen, et al.

Pageof 2